AlphaYouBM
Insider buying
Brett Matthew Hall bought $25K of Immuneering Corp (IMRX) stock
Brett Matthew Hall, Chief Scientific Officer of Immuneering Corp (IMRX), bought 6,035 shares of IMRX stock worth $25K, per an SEC Form 4 filed Jun 16, 2026.
It was an open-market purchase.
The trade happened on Jun 15, 2026, 1 day before it was made public.
IMRX has moved -6.0% since the trade date, from $4.19 to $3.94 (Oct 9, 2026 close).
- Traded
- Jun 15, 2026
- Disclosed
- Jun 16, 2026
- Filing delay
- 1 day
- Price since
- -6.0%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More IMRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.